TMDX saw its Momentum Indicator move below the 0 level on December 03, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned negative. In of the 90 cases, the stock moved further down in the following days. The odds of a decline are at .
The 50-day moving average for TMDX moved below the 200-day moving average on November 20, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for TMDX entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TMDX's RSI Oscillator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for TMDX just turned positive on November 12, 2024. Looking at past instances where TMDX's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .
TMDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.513) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (9.881) is also within normal values, averaging (43.338).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TMDX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a developer of a proprietary system for preserving human organs for transplant
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GTFPX | 28.22 | N/A | N/A |
Goldman Sachs International Eq ESG P | |||
VEIRX | 96.43 | -0.67 | -0.69% |
Vanguard Equity-Income Adm | |||
ATGYX | 43.85 | -0.31 | -0.70% |
Cantor Fitzgerald Equity Opp Inst | |||
FIQOX | 36.25 | -0.40 | -1.09% |
Fidelity Advisor Worldwide Z | |||
QGIAX | 26.50 | -1.98 | -6.94% |
Pear Tree Quality Institutional |
A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with RXST. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then RXST could also see price increases.
Ticker / NAME | Correlation To TMDX | 1D Price Change % | ||
---|---|---|---|---|
TMDX | 100% | +2.31% | ||
RXST - TMDX | 36% Loosely correlated | -1.17% | ||
LIVN - TMDX | 32% Poorly correlated | -0.42% | ||
ALGN - TMDX | 30% Poorly correlated | -0.56% | ||
PRCT - TMDX | 30% Poorly correlated | -0.96% | ||
RDNT - TMDX | 29% Poorly correlated | -1.87% | ||
More |